NDAORALCAPSULE, DELAYED RELEASE
Approved
Jun 2020
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
20
Mechanism of Action
Somatostatin Receptor Agonists
Pharmacologic Class:
Somatostatin Analog
Clinical Trials (5)
Preventing Postoperative Complications in Patients Undergoing High-risk Pancreatoduodenectomy With a Bundle Approach Including Hydrocortisone, Octreotide, and the Teres Ligament Patch (PANENCA)
Started Sep 2025
400 enrolled
Pancreas Head CancerPancreas AdenocarcinomaIPMN, Pancreatic+7 more
A Trial to Assess the Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With PLD
Started Jun 2022
71 enrolled
Polycystic Liver Disease
A Feasibility Study of Octreotide Infusion During Liver Transplant.
Started May 2022
30 enrolled
Liver TransplantationRenal Failure
A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With GEP-NET
Started Oct 2021
332 enrolled
Gastro-enteropancreatic Neuroendocrine Tumor
Bioequivalence Study of Two Octreotide Microsphere Formulations in Healthy Volunteers
Started Jun 2021
240 enrolled
Healthy Volunteers
Loss of Exclusivity
LOE Date
Dec 28, 2040
180 months away
Patent Expiry
Dec 28, 2040
Exclusivity Expiry
Jun 26, 2027